Chemotherapy and targeted therapies for meningiomas: what is the evidence?

T Graillon, E Tabouret, O Chinot - Current Opinion in Neurology, 2021 - journals.lww.com
Despite a low evidence level, some systemic therapies may be considered for patients with
recurrent meningioma not amenable to further surgery or radiotherapy. In recurrent high …
被引用次数：20 相关文章

[引用][C] Chemotherapy and targeted therapies for meningiomas: what is the evidence?

T Graillon, E Tabouret, O Chinot - Current Opinion in Neurology, 2021 - hal.science
Chemotherapy and targeted therapies for meningiomas: what is the evidence? - Archive
ouverte HAL Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) …

Chemotherapy and targeted therapies for meningiomas: what is the evidence?

T Graillon, E Tabouret, O Chinot - Current Opinion in Neurology, 2021 - europepmc.org
Despite a low evidence level, some systemic therapies may be considered for patients with
recurrent meningioma not amenable to further surgery or radiotherapy. In recurrent high …

Chemotherapy and targeted therapies for meningiomas: what is the evidence?

T Graillon, E Tabouret, O Chinot - Current Opinion in Neurology, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose of review</jats: title>< jats: p> Although most
meningiomas are slow growing tumors mainly controlled by surgery with or without …

Chemotherapy and targeted therapies for meningiomas: what is the evidence?

T Graillon, E Tabouret, O Chinot - Current opinion in …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose of review Although most meningiomas are slow growing tumors mainly controlled
by surgery with or without radiotherapy, aggressive meningiomas that fail these …

Chemotherapy and targeted therapies for meningiomas: what is the evidence?

T Graillon, E Tabouret, O Chinot - Current Opinion in Neurology, 2021 - ingentaconnect.com
Purpose of review Although most meningiomas are slow growing tumors mainly controlled
by surgery with or without radiotherapy, aggressive meningiomas that fail these …